EE9600011A - Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid - Google Patents

Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid

Info

Publication number
EE9600011A
EE9600011A EE9600011A EE9600011A EE9600011A EE 9600011 A EE9600011 A EE 9600011A EE 9600011 A EE9600011 A EE 9600011A EE 9600011 A EE9600011 A EE 9600011A EE 9600011 A EE9600011 A EE 9600011A
Authority
EE
Estonia
Prior art keywords
pyridinyl
benzimidazole derivatives
dialkoxy
novel
novel dialkoxy
Prior art date
Application number
EE9600011A
Other languages
English (en)
Estonian (et)
Inventor
Lennart Lindberg Per
Oskar Sverker Von Unge Per
Elisabeth Sund�n Gunnel
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9600011A publication Critical patent/EE9600011A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9600011A 1994-05-27 1995-05-11 Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid EE9600011A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (1)

Publication Number Publication Date
EE9600011A true EE9600011A (et) 1996-04-15

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600011A EE9600011A (et) 1994-05-27 1995-05-11 Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid

Country Status (18)

Country Link
EP (1) EP0712401A1 (xx)
JP (1) JPH09504557A (xx)
CN (1) CN1128997A (xx)
AU (1) AU2633095A (xx)
BR (1) BR9506235A (xx)
CA (1) CA2166988A1 (xx)
CZ (1) CZ24396A3 (xx)
EE (1) EE9600011A (xx)
FI (1) FI960367A0 (xx)
HU (1) HU9600005D0 (xx)
IL (1) IL113604A0 (xx)
IS (1) IS4321A (xx)
MA (1) MA23563A1 (xx)
NO (1) NO960268D0 (xx)
PL (1) PL312692A1 (xx)
TN (1) TNSN95062A1 (xx)
WO (1) WO1995032959A1 (xx)
ZA (1) ZA954125B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
BR9915421A (pt) * 1998-11-18 2001-08-07 Astrazeneca Ab Processo para a fabricação de sais alcalinos levemente solúveis ou menos solúveis de heterociclos de sulfinila substituìda, forma de dosagem farmacêutica, uso da mesma, método de tratamento de doenças gastrointestinais, e, processo para a fabricação de uma forma de dosagem farmacêutica.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
US8247440B2 (en) 2008-02-20 2012-08-21 Curators Of The University Of Missouri Composition comprising omeprazole, lansoprazole and at least one buffering agent
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3049367B2 (ja) * 1990-06-20 2000-06-05 アストラゼネカ・アクチエボラーグ ジアルコキシ−ピリジニル−ベンズイミダゾール誘導体、その製造方法およびそれを含む医薬
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung

Also Published As

Publication number Publication date
JPH09504557A (ja) 1997-05-06
AU2633095A (en) 1995-12-21
ZA954125B (en) 1995-11-27
MA23563A1 (fr) 1995-12-31
FI960367A (fi) 1996-01-26
NO960268L (no) 1996-01-23
EP0712401A1 (en) 1996-05-22
TNSN95062A1 (fr) 1996-02-06
IS4321A (is) 1996-01-17
PL312692A1 (en) 1996-05-13
NO960268D0 (no) 1996-01-23
BR9506235A (pt) 1997-08-12
HU9600005D0 (en) 1996-03-28
FI960367A0 (fi) 1996-01-26
WO1995032959A1 (en) 1995-12-07
CN1128997A (zh) 1996-08-14
CZ24396A3 (en) 1996-06-12
IL113604A0 (en) 1995-08-31
CA2166988A1 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
FI955927A (fi) Substituoidut 1H-imidatsolit
ATA166795A (de) Bis-resorcinyltriazine
ATA163695A (de) 2-hydroxyphenyltriazine
DE69534718D1 (de) Substituierte 9-alkyladenine
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
BR9509793A (pt) Derivados de tiofeneno
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
FI945365A (fi) Tilaajaverkkoelementti
DE69527786T2 (de) Diaminomethyliden-derivate
NO965233D0 (no) Deacetoksytaksol-derivat
ATA108995A (de) Differenzdruckakkumulator
DE69521745T2 (de) Diazacycloalkanalkylsulfonamid-derivat
KR950033309U (ko) 줄연장
DE59509209D1 (de) Diphenyloxazolin-derivate
NO970144D0 (no) Trifluormetylkinolinkarboksylsyre-derivat
BR9509559A (pt) Azolilulsolfonilfeniluracilas substituídas
DE69510792T2 (de) Naphtochinonderivate
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
ATA11894A (de) Stauförderbahn
BR9506613A (pt) Derivados de feniltio-oxazolinas
DE59510274D1 (de) Substituierte biphenyloxazoline
BR9508450A (pt) Derivados de n-alcóxi-amidina
NO951573D0 (no) Tiadiazinon-derivater